Summary:
- Researchers have identified a specific genetic pathway, involving the gene *Sox11*, that acts as a critical regulator in the regeneration of axons within the central nervous system.
- The study highlights how manipulating these genetic mechanisms could potentially overcome the natural inhibitory environment of the CNS, offering new therapeutic avenues for treating spinal cord injuries and neurodegenerative diseases.